Glioblastoma: Molecular analysis and clinical implications Journal Article


Authors: Huse, J. T.; Holland, E.; De Angelis, L. M.
Article Title: Glioblastoma: Molecular analysis and clinical implications
Abstract: Glioblastoma, the most common malignant primary brain tumor, carries an invariably poor prognosis. Targeting underlying biological foundations of the disease will be crucial to developing more effective treatment strategies. Although increasing evidence clearly indicates that glioblastoma is a molecularly heterogeneous disorder, recent large-scale expression profiling has provided a framework for categorizing the tumor into 3 to 4 distinct subclasses, each with its own characteristic genomic alterations. As such, there remains the enticing possibility that glioblastoma subclasses themselves might represent predictive biomarkers, particularly in the context of specific targeted agents. This review focuses on how best to ascertain the functional relevance of molecular subclass in glioblastoma through both preclinical and clinical investigations. The availability of appropriate mouse modeling systems along with expanded molecular profiling capabilities in the clinical setting should aid such efforts. However, significant systematic challenges remain, particularly in the setting of clinical trials. Copyright © 2013 by Annual Reviews.
Keywords: signal transduction; cancer surgery; gene mutation; gene deletion; review; erlotinib; disease classification; multimodality cancer therapy; nonhuman; cancer radiotherapy; temozolomide; brain tumor; glioma; phenotype; imatinib; gene overexpression; mesenchyme cell; melanoma; gene amplification; genetic transcription; chronic myeloid leukemia; proteomics; lung adenocarcinoma; dna; glioblastoma; vatalanib; ionizing radiation; targeted therapy; dna microarray; perifosine; animal models; epithelial mesenchymal transition; crizotinib; vemurafenib; cancer prognosis
Journal Title: Annual Review of Medicine
Volume: 64
ISSN: 0066-4219
Publisher: Annual Reviews  
Date Published: 2013-01-01
Start Page: 59
End Page: 70
Language: English
DOI: 10.1146/annurev-med-100711-143028
PROVIDER: scopus
PUBMED: 23043492
DOI/URL:
Notes: --- - "Export Date: 1 March 2013" - "CODEN: ARMCA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eric Holland
    225 Holland
  2. Jason T Huse
    143 Huse